Therapeutic Targeting of Protein Tyrosine Phosphatases from <i>Mycobacterium tuberculosis</i>
Tuberculosis (TB) is an airborne infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb). According to the World Health Organization, an estimated 10 million people developed TB in 2018. The occurrence of drug-resistant TB demands therapeutic agents with novel mechanisms of...
Main Authors: | Kasi Viswanatharaju Ruddraraju, Devesh Aggarwal, Zhong-Yin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/1/14 |
Similar Items
-
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
by: Elisa Pardella, et al.
Published: (2020-09-01) -
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
by: Akanksha Verma, et al.
Published: (2022-12-01) -
Flavonoid Mixture Inhibits <i>Mycobacterium tuberculosis</i> Survival and Infectivity
by: Ruoqiong Cao, et al.
Published: (2019-02-01) -
Chemical Epigenetic Regulation Secondary Metabolites Derived from <i>Aspergillus sydowii</i> DL1045 with Inhibitory Activities for Protein Tyrosine Phosphatases
by: Xuan Shi, et al.
Published: (2024-01-01) -
Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms
by: James P. Dalton, et al.
Published: (2016-11-01)